Sanofi India receives ₹24.10 Lakh tax demand order for FY19
Sanofi India Limited received a tax demand order of ₹24.10 Lakh for FY19 from Gujarat State Tax authorities. The demand includes ₹12.96 Lakh tax, ₹9.85 Lakh interest, and ₹1.30 Lakh penalty related to excess ITC claims. The company plans to appeal the order.
The total demand of ₹24.10 Lakh is relatively small compared to Sanofi India's overall revenue and operations. The company also plans to appeal the order, which may mitigate the impact.
The company has received a tax demand order with interest and penalty, which is a negative development.
Sanofi India Limited has received an order from the Office of the Deputy Commissioner of State Tax, Ahmedabad, Gujarat, concerning the Financial Year 2018-19. The order determines a total demand of ₹24,10,359, which includes a tax component of ₹12,95,930, interest of ₹9,84,836, and a penalty of ₹1,29,593.
The company received this order on 23rd December 2025, with the order itself being dated 23rd December 2025. The alleged violation pertains to the denial of excess claim of Input Tax Credit (ITC) in GSTR-3B compared to the ITC available in GSTR-2A.
Sanofi India Limited intends to appeal this order before the Higher Tax Authorities. The company has stated that the impact on its financial, operational, or other activities, quantifiable in monetary terms, is subject to the outcome of this appeal.
What to do with a filing like this
Sanofi India Limited filed this with the NSE as a statutory disclosure, categorised under other regulatory filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Sanofi India Limited. Read the original for the full detail.